Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Aleksander M. Bogdanski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8632-9277; OpenAlex author ID A5000868787. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2024: 3 papers · 2025: 3 papers · 2026: 4 papers

Papers 10

  1. Optimal upper gastrointestinal surveillance strategies for gastric, small bowel and pancreatic cancer detection in Lynch syndrome. First author DOI 10.1007/s10689-026-00567-y↗
  2. Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort study. Co-author DOI 10.1016/j.eclinm.2026.103755↗
  3. Longitudinal body composition changes distinguish pancreatic ductal adenocarcinoma from controls in a pre-diagnostic CT cohort. Co-author DOI 10.1016/j.pan.2026.09.008↗
  4. Association Between Computed Tomography-Based AI-Derived Body Composition and Survival in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.14309/ajg.0000000000003896↗
  5. Pancreatic cancer surveillance not recommended for familial adenomatous polyposis: a fine and gray risk analysis. Co-author DOI 10.1007/s10689-025-00512-5↗
  6. Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals. Co-author DOI 10.1016/j.bpg.2025.101974↗
  7. Protein N-Glycosylation Traits Combined with CA19-9 Accurately Distinguish Pancreatic Cancer Cases From Healthy Controls and Benign Pancreatic Diseases. Co-author DOI 10.1097/mpa.0000000000002517↗
  8. Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer. Co-author DOI 10.1007/s10689-024-00368-1↗
  9. The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance. Co-author DOI 10.1097/mpa.0000000000002335↗
  10. Small Field-of-View T2-Weighted MRI of the pancreas in a Screening Setting for Hereditary Pancreatic Cancer: Improving Image Quality Through Radial K-Space Sam… First author DOI 10.26502/jrci.2809093↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Monique Esther van Leerdam · 8 shared papers, 2024–2026 · strength 2.18
  2. Derk C.F. Klatte · 7 shared papers, 2024–2026 · strength 1.75
  3. Jeanin Elise van Hooft · 6 shared papers, 2024–2026 · strength 1.42
  4. Michael B. Wallace · 5 shared papers, 2025–2026 · strength 1.32
  5. Yan Bi · 3 shared papers, 2025–2026 · strength 0.80
  6. Bas Boekestijn · 3 shared papers, 2024 · strength 0.68
  7. Martin N.J.M. Wasser · 3 shared papers, 2024 · strength 0.68
  8. Bert A. Bonsing · 3 shared papers, 2024–2025 · strength 0.62
  9. J. Sven D. Mieog · 2 shared papers, 2024–2026 · strength 0.46
  10. Tim Marwitz · 1 shared paper, 2026 · strength 0.43
  11. Pilar Acedo · 1 shared paper, 2025 · strength 0.33
  12. Che G. Ngufor · 1 shared paper, 2026 · strength 0.29
  13. Koen J.H. Wijsman · 1 shared paper, 2026 · strength 0.28
  14. Hani M. Babiker · 1 shared paper, 2026 · strength 0.28
  15. Manfred Wuhrer · 1 shared paper, 2025 · strength 0.23
  16. Yuri E. M. van der Burgt · 1 shared paper, 2025 · strength 0.23
  17. Wilma E. Mesker · 1 shared paper, 2025 · strength 0.23
  18. Lisa A. Boardman · 1 shared paper, 2025 · strength 0.20
  19. Douglas L. Riegert‐Johnson · 1 shared paper, 2025 · strength 0.20
  20. Lydia G. van der Geest · 1 shared paper, 2025 · strength 0.20
  21. Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.20
  22. Thomas P. Potjer · 1 shared paper, 2024 · strength 0.18
  23. Hans F. A. Vasen · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.